Lumos Pharma
LUMO

股本结构

单位：万股
公告日期 2024-11-07 2024-11-07 2024-08-02 2024-08-02 2024-04-12 2024-05-15
证券总股本 864.86 864.82 812.40 812.32 811.65 810.71
普通股本 864.86 864.82 812.40 812.32 811.65 810.71
优先股 未披露 未披露 未披露 未披露 未披露 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2024-11-05 2024-09-30 2024-07-26 2024-06-30 2024-04-08 2024-03-31
注释：中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本（万股） 变动后优先股（万股） 变动原因 变动日期
2024-11-07 864.86 未披露 定期报告 2024-11-05
2024-11-07 864.82 未披露
更多>>
From June 30, 2024 to September 30, 2024 Stock issued upon vesting of restricted stock units Shares surrendered for tax withholding on vested awards Stock issued under the Controlled Equity Offering, net of costs
2024-09-30
2024-08-02 812.40 未披露 定期报告 2024-07-26
2024-08-02 812.32 未披露
更多>>
From March 31, 2024 to June 30, 2024 Stock issued upon vesting of restricted stock units Shares surrendered for tax withholding on vested awards Stock issued under stock purchase plan
2024-06-30
2024-04-12 811.65 未披露 定期报告 2024-04-08
2024-05-15 810.71 未披露
更多>>
From December 31, 2023 to March 31, 2024 Stock issued upon vesting of restricted stock units Shares surrendered for tax withholding on vested awards
2024-03-31
2024-03-07 810.71 未披露 定期报告 2024-03-01
2024-03-07 810.26 未披露
更多>>
From December 31,2022 to December 31,2023 Stock issued under the Controlled Equity OfferingSM, net of costs Stock issued upon vesting of restricted stock units Shares surrendered for tax withholding on vested awards Stock issued under stock purchase plan Repurchases of common stock
2023-12-31
2023-11-07 791.46 未披露
更多>>
From June 30, 2023 to September 30, 2023 Repurchases of common stock Stock issued upon vesting of restricted stock units Shares surrendered for tax withholding on vested awards
2023-09-30
2023-08-10 793.54 未披露 定期报告 2023-08-07
2023-08-10 804.13 未披露
更多>>
From March 31, 2023 to June 30, 2023 Sale of shares under stock purchase plan Stock issued upon vesting of restricted stock units Shares surrendered for tax withholding on vested awards Repurchases of common stock
2023-06-30
2023-05-05 817.05 未披露 定期报告 2023-05-01
2023-05-05 818.33 未披露
更多>>
From December 31, 2022 to March 31, 2023 Repurchases of common stock Stock issued upon vesting of restricted stock units Shares surrendered for tax withholding on vested awards
2023-03-31
2023-03-31 819.92 未披露 定期报告 2023-03-13
2023-03-07 821.93 未披露 定期报告 2023-03-03
2023-03-07 826.80 未披露
更多>>
From December 31, 2021 to December 31, 2022 Stock issued upon vesting of restricted stock units Shares surrendered for tax withholding on vested awards Sale of shares under stock purchase plan Repurchases of common stock Exercise of stock options
2022-12-31
2022-11-14 837.62 未披露 定期报告 2022-11-04
2022-11-14 837.53 未披露
更多>>
From June 30, 2022 to September 30, 2022 Exercise of stock options Repurchases of common stock Stock issued upon vesting of restricted stock units Shares surrendered for tax withholding on vested awards
2022-09-30
2022-08-19 839.61 未披露 定期报告 2022-08-17
2022-08-10 838.17 未披露 定期报告 2022-08-03
2022-08-10 837.76 未披露
更多>>
From March 31, 2022 to June 30, 2022 Exercise of stock options Sale of shares under stock purchase plan Stock issued upon vesting of restricted stock units Shares surrendered for tax withholding on vested awards
2022-06-30
2022-05-11 836.92 未披露 定期报告 2022-05-06
2022-05-11 835.86 未披露
更多>>
From December 31, 2021 to March 31, 2022 Stock issued upon vesting of restricted stock units Shares surrendered for tax withholding on vested awards
2022-03-31
2022-03-11 835.86 未披露 定期报告 2022-03-04
2021-08-06 835.74 未披露
更多>>
From March 31, 2021 to June 30, 2021 Exercise of stock options Sale of shares under stock purchase plan Stock issued upon vesting of restricted stock units Shares surrendered for tax withholding on vested awards
2021-06-30
2021-05-06 834.47 未披露 定期报告 2021-04-30
2021-05-06 833.22 未披露
更多>>
From December 31, 2020 to March 31, 2021 Exercise of stock options Stock issued upon vesting of restricted stock units Shares surrendered for tax withholding on vested awards
2021-03-31
2021-04-06 833.22 未披露 定期报告 2021-03-22
2021-03-09 832.56 未披露 定期报告 2021-03-05
2021-03-09 830.53 未披露
更多>>
From December 31, 2019 to December 31, 2020 Conversion of preferred stock into common stock upon merger Issuance of common stock to former stockholders of NewLink upon merger Exercise of stock options Sales of shares under stock purchase plan
2020-12-31
2020-11-12 829.71 未披露 定期报告 2020-11-06
2020-08-14 829.33 未披露
更多>>
From March 31, 2020 to June 30, 2020 Sales of shares under stock purchase plan
2020-06-30
2020-06-02 829.28 未披露
更多>>
From December 31,2019 to March 31, 2020 Conversion of preferred stock into common stock upon merger Issuance of common stock to former stockholders of NewLink upon merger
2020-03-31
2020-03-18 825.51 未披露
更多>>
On March 18, 2020, NewLink Genetics Corporation completed its business combination with Lumos Pharma, Inc. (“Lumos”) in accordance with the terms of the Agreement and Plan of Merger and Reorganization, dated as of September 30, 2019, by and among the Company, Cyclone Merger Sub, Inc. (“Merger Sub”), and Lumos (as amended, the “Merger Agreement”), pursuant to which Merger Sub merged with and into Lumos, with Lumos surviving as a wholly-owned subsidiary of the Company (the “Merger”). Also on March 18, 2020, and prior to the effective time of the Merger (the “Effective Time”), the Company effected a 1-for-9 reverse stock split of its common stock. Immediately following the Reverse Stock Split and the completion of the Merger, there were approximately 8,255,126 shares of the Company’s common stock outstanding.
2020-03-19
2020-03-03 3732.84 未披露 定期报告 2020-02-25
2020-03-03 3732.51 未披露
更多>>
from December 31, 2018 to December 31, 2019 Vesting of restricted stock awards Sales of shares under stock purchase plan Repurchase of common stock
2019-12-31
2019-11-06 3731.41 未披露
更多>>
from June 30, 2019 to September 30, 2019 Restricted stock vested Repurchase of common stock
2019-09-30
2019-08-08 3731.26 未披露 定期报告 2019-08-06
2019-08-08 3730.10 未披露
更多>>
From March 31, 2019 to June 30, 2019 Restricted stock vested Sales of shares under stock purchase plan Repurchase of common stock
2019-06-30
2019-07-01 3727.70 未披露 定期报告 2019-06-26
2019-05-08 3727.61 未披露
更多>>
From December 31,2018 to March 31, 2019 Restricted stock vested Repurchase of common stock
2019-03-31
2019-03-05 3727.61 未披露 定期报告 2019-02-27
2019-03-05 3725.12 未披露
更多>>
From December 31,2017 to December 31,2018 Exercise of stock options and vesting of restricted stock awards Sales of shares under stock purchase plan Shares withheld for statutory tax withholding
2018-12-31
2018-11-02 3722.46 未披露 定期报告 2018-10-30
2018-11-02 3721.69 未披露
更多>>
From December 31, 2017 to September 30, 2018 Exercise of stock options and restricted stock vested Sales of shares under stock purchase plan Repurchase of common stock
2018-09-30
2018-08-06 3721.43 未披露 定期报告 2018-08-01
2018-08-06 3719.81 未披露
更多>>
from December 31, 2017 to June 30, 2018 Exercise of stock options and restricted stock vested Sales of shares under stock purchase plan Shares withheld for statutory tax withholding
2018-06-30
2018-05-09 3716.51 未披露
更多>>
From December 31, 2017 to March 31, 2018 Exercise of stock options and restricted stock vested Repurchase of common stock
2018-03-31
2018-03-05 3715.58 未披露 定期报告 2018-03-02
2018-03-05 3710.96 未披露
更多>>
from December 31, 2016 to December 31, 2017 Exercise of stock options and vesting of restricted stock awards Sales of shares under stock purchase plan Issuance of common stock under the ATM Offering (net of offering costs of $561 thousand) Issuance of common stock under public offering (net of offering costs of $3.7 million) Shares withheld for statutory tax withholding
2017-12-31
2017-11-03 3707.72 未披露 定期报告 2017-10-31
2017-11-03 3131.98 未披露
更多>>
From December 31, 2016 to September 30, 2017 Exercise of stock options and restricted stock vested Sales of shares under stock purchase plan Repurchase of common stock Issuance of common stock under the ATM Offering (net of offering costs of $561)
2017-09-30
2017-08-03 2942.10 未披露 定期报告 2017-08-01
2017-08-03 2928.13 未披露
更多>>
From December 31, 2016 to June 30, 2017 Exercise of stock options and restricted stock vested Sales of shares under stock purchase plan Repurchase of common stock
2017-06-30
2017-05-05 2922.57 未披露 定期报告 2017-05-03
2017-05-05 2921.97 未披露
更多>>
from December 31, 2016 to March 31, 2017 Exercise of stock options and restricted stock vested Repurchase of common stock
2017-03-31
2017-03-31 2921.92 未披露 定期报告 2017-03-15
2017-03-06 2921.64 未披露 定期报告 2017-02-28
2017-03-06 2916.37 未披露
更多>>
From December 31, 2015 to December 31, 2016 Exercise of stock options and vesting of restricted stock awards Sales of shares under stock purchase plan Shares withheld for statutory tax withholding
2016-12-31
2016-11-08 2913.46 未披露 定期报告 2016-11-02
2016-11-03 2913.22 未披露 定期报告 2016-10-26
2016-11-08 2909.17 未披露
更多>>
From December 31, 2015 to September 30, 2016 Exercise of stock options and restricted stock vested Sale of shares under stock purchase plan Shares withheld for statutory tax withholding
2016-09-30
2016-08-05 2896.94 未披露 定期报告 2016-08-02
2016-08-05 2896.23 未披露
更多>>
from December 31, 2015 to June 30, 2016 Exercise of stock options and restricted stock vested Sale of shares under stock purchase plan Shares withheld for statutory tax withholding
2016-06-30
2016-05-20 2889.74 未披露 定期报告 2016-05-18
2016-04-29 2886.13 未披露 定期报告 2016-04-26
2016-04-29 2886.09 未披露
更多>>
from December 31, 2015 to March 31, 2016 Exercise of stock options and restricted stock vested
2016-03-31
2016-04-06 2886.07 未披露 定期报告 2016-03-28
2016-02-29 2885.85 未披露 定期报告 2016-02-23
2016-02-29 2881.41 未披露
更多>>
from December 31, 2014 to December 31, 2015 Exercise of stock options and vesting of restricted stock awards Sales of shares under stock purchase plan Issuance of common stock under the ATM Offering (net of offering costs of $54) Shares withheld for statutory tax withholding Shares issued from treasury
2015-12-31
2015-11-06 2878.54 未披露 定期报告 2015-11-03
2015-08-06 2871.84 未披露 定期报告 2015-07-29
2015-05-11 2859.63 未披露 定期报告 2015-05-07
2015-03-16 2847.86 未披露 定期报告 2015-03-10
2015-03-19 2842.81 未披露 定期报告 2015-03-02
2014-11-10 2795.96 未披露 定期报告 2014-11-06
2014-08-05 2790.90 未披露 定期报告 2014-07-31
2014-05-08 2787.42 未披露 定期报告 2014-05-06
2014-03-12 2786.14 未披露 定期报告 2014-03-07
2014-03-21 2785.67 未披露 定期报告 2014-03-03
2013-11-12 2570.63 未披露 定期报告 2013-11-05
2013-08-08 2570.14 未披露 定期报告 2013-08-05
2013-03-15 2560.28 未披露 定期报告 2013-03-12
2012-10-31 2091.53 未披露 定期报告 2012-10-24
2012-09-21 2090.06 未披露 定期报告 2012-09-20
2012-08-14 2089.82 未披露 定期报告 2012-08-10
2012-03-30 2066.20 未披露 定期报告 2012-03-19
2011-12-16 367.86 42.00
更多>>
from December 31, 2010 to September 30, 2011 Stock compensation Exercise of stock options Conversion of preferred stock to common stock Issuance of dividend paid in common stock
2011-09-30
From June 30, 2024 to September 30, 2024 Stock issued upon vesting of restricted stock units Shares surrendered for tax withholding on vested awards Stock issued under the Controlled Equity Offering, net of costs
From March 31, 2024 to June 30, 2024 Stock issued upon vesting of restricted stock units Shares surrendered for tax withholding on vested awards Stock issued under stock purchase plan
From December 31, 2023 to March 31, 2024 Stock issued upon vesting of restricted stock units Shares surrendered for tax withholding on vested awards
From December 31,2022 to December 31,2023 Stock issued under the Controlled Equity OfferingSM, net of costs Stock issued upon vesting of restricted stock units Shares surrendered for tax withholding on vested awards Stock issued under stock purchase plan Repurchases of common stock
From June 30, 2023 to September 30, 2023 Repurchases of common stock Stock issued upon vesting of restricted stock units Shares surrendered for tax withholding on vested awards
From March 31, 2023 to June 30, 2023 Sale of shares under stock purchase plan Stock issued upon vesting of restricted stock units Shares surrendered for tax withholding on vested awards Repurchases of common stock
From December 31, 2022 to March 31, 2023 Repurchases of common stock Stock issued upon vesting of restricted stock units Shares surrendered for tax withholding on vested awards
From December 31, 2021 to December 31, 2022 Stock issued upon vesting of restricted stock units Shares surrendered for tax withholding on vested awards Sale of shares under stock purchase plan Repurchases of common stock Exercise of stock options
From June 30, 2022 to September 30, 2022 Exercise of stock options Repurchases of common stock Stock issued upon vesting of restricted stock units Shares surrendered for tax withholding on vested awards
From March 31, 2022 to June 30, 2022 Exercise of stock options Sale of shares under stock purchase plan Stock issued upon vesting of restricted stock units Shares surrendered for tax withholding on vested awards
From December 31, 2021 to March 31, 2022 Stock issued upon vesting of restricted stock units Shares surrendered for tax withholding on vested awards
From March 31, 2021 to June 30, 2021 Exercise of stock options Sale of shares under stock purchase plan Stock issued upon vesting of restricted stock units Shares surrendered for tax withholding on vested awards
From December 31, 2020 to March 31, 2021 Exercise of stock options Stock issued upon vesting of restricted stock units Shares surrendered for tax withholding on vested awards
From December 31, 2019 to December 31, 2020 Conversion of preferred stock into common stock upon merger Issuance of common stock to former stockholders of NewLink upon merger Exercise of stock options Sales of shares under stock purchase plan
From March 31, 2020 to June 30, 2020 Sales of shares under stock purchase plan
From December 31,2019 to March 31, 2020 Conversion of preferred stock into common stock upon merger Issuance of common stock to former stockholders of NewLink upon merger
On March 18, 2020, NewLink Genetics Corporation completed its business combination with Lumos Pharma, Inc. (“Lumos”) in accordance with the terms of the Agreement and Plan of Merger and Reorganization, dated as of September 30, 2019, by and among the Company, Cyclone Merger Sub, Inc. (“Merger Sub”), and Lumos (as amended, the “Merger Agreement”), pursuant to which Merger Sub merged with and into Lumos, with Lumos surviving as a wholly-owned subsidiary of the Company (the “Merger”). Also on March 18, 2020, and prior to the effective time of the Merger (the “Effective Time”), the Company effected a 1-for-9 reverse stock split of its common stock. Immediately following the Reverse Stock Split and the completion of the Merger, there were approximately 8,255,126 shares of the Company’s common stock outstanding.
from December 31, 2018 to December 31, 2019 Vesting of restricted stock awards Sales of shares under stock purchase plan Repurchase of common stock
from June 30, 2019 to September 30, 2019 Restricted stock vested Repurchase of common stock
From March 31, 2019 to June 30, 2019 Restricted stock vested Sales of shares under stock purchase plan Repurchase of common stock
From December 31,2018 to March 31, 2019 Restricted stock vested Repurchase of common stock
From December 31,2017 to December 31,2018 Exercise of stock options and vesting of restricted stock awards Sales of shares under stock purchase plan Shares withheld for statutory tax withholding
From December 31, 2017 to September 30, 2018 Exercise of stock options and restricted stock vested Sales of shares under stock purchase plan Repurchase of common stock
from December 31, 2017 to June 30, 2018 Exercise of stock options and restricted stock vested Sales of shares under stock purchase plan Shares withheld for statutory tax withholding
From December 31, 2017 to March 31, 2018 Exercise of stock options and restricted stock vested Repurchase of common stock
from December 31, 2016 to December 31, 2017 Exercise of stock options and vesting of restricted stock awards Sales of shares under stock purchase plan Issuance of common stock under the ATM Offering (net of offering costs of $561 thousand) Issuance of common stock under public offering (net of offering costs of $3.7 million) Shares withheld for statutory tax withholding
From December 31, 2016 to September 30, 2017 Exercise of stock options and restricted stock vested Sales of shares under stock purchase plan Repurchase of common stock Issuance of common stock under the ATM Offering (net of offering costs of $561)
From December 31, 2016 to June 30, 2017 Exercise of stock options and restricted stock vested Sales of shares under stock purchase plan Repurchase of common stock
from December 31, 2016 to March 31, 2017 Exercise of stock options and restricted stock vested Repurchase of common stock
From December 31, 2015 to December 31, 2016 Exercise of stock options and vesting of restricted stock awards Sales of shares under stock purchase plan Shares withheld for statutory tax withholding
From December 31, 2015 to September 30, 2016 Exercise of stock options and restricted stock vested Sale of shares under stock purchase plan Shares withheld for statutory tax withholding
from December 31, 2015 to June 30, 2016 Exercise of stock options and restricted stock vested Sale of shares under stock purchase plan Shares withheld for statutory tax withholding
from December 31, 2015 to March 31, 2016 Exercise of stock options and restricted stock vested
from December 31, 2014 to December 31, 2015 Exercise of stock options and vesting of restricted stock awards Sales of shares under stock purchase plan Issuance of common stock under the ATM Offering (net of offering costs of $54) Shares withheld for statutory tax withholding Shares issued from treasury
from December 31, 2010 to September 30, 2011 Stock compensation Exercise of stock options Conversion of preferred stock to common stock Issuance of dividend paid in common stock
同花顺个股页面 | 模拟炒股 | 股民学校 | 手机炒股| 联系我们

免责声明:本信息由同花顺金融研究中心提供，仅供参考，同花顺金融研究中心力求但不保证数据的完全准确，如有错漏请以中国证监会指定上市公司信息披露媒体为准，同花顺金融研究中心不对因该资料全部或部分内容而引致的盈亏承担任何责任。用户个人对服务的使用承担风险。同花顺对此不作任何类型的担保。同花顺不担保服务一定能满足用户的要求，也不担保服务不会受中断，对服务的及时性，安全性，出错发生都不作担保。同花顺对在同花顺上得到的任何信息服务或交易进程不作担保。同花顺提供的包括同花顺理财的所有文章，数据，不构成任何的投资建议，用户查看或依据这些内容所进行的任何行为造成的风险和结果都自行负责，与同花顺无关。

【免责声明】本产品中的行情数据及资讯信息来源于第三方，长江证券不对收集数据的版权、真实性、准确性及传输过程中发生的传送错误承担法律责任。本内容仅供参考，不作为投资决策依据，长江证券不对因据此操作产生的盈亏承担任何责任。投资有风险，入市需谨慎。